TETRALOGIC PHARMACEUTICALS Corp – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 09/30/16 Q3

ended 06/30/16 Q2

ended 03/31/16 Q1

ended 12/31/15 FY 2015

ended 09/30/15 Q3

Prospectuses and Registrations Filter

Securities registration termination

Removal from listing

Updated info for already-effective prospectus

Amendment to registration of securities for employees

Prospectus supplement for primary offering

Ownership Filter

Robins David C.

Robins David C.

Robins David C.

Robins David C.

Robins David C.

News Filter

Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

Material Definitive Agreement, Financial Statements or Exhibits

Announces Agreements to Sell SMAC Mimetic and HDAC Inhibitor Assets to Medivir and to Restructure Its Convertible Senior Notes and Delisting of Common Stock

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Proxies Filter

Definitive proxy

Preliminary proxy related to merger

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Notice of effectiveness

Confidential treatment order

Notice of effectiveness

Correspondence with the SEC